Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00371150
Status:
COMPLETED
Last Update Posted:
2012-04-16
First Post:
2006-08-29
Brief Title:
Effect of Entecavir in BlacksAfrican Americans and Hispanics With Chronic Hepatitis B Virus HBV Infection
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Study Overview
Official Title:
A Study to Describe the Antiviral Effect of Entecavir ETV in BlacksAfrican Americans and Hispanics With Chronic Hepatitis B Virus HBV Infection Who Are Nucleoside-Naive
Status:
COMPLETED
Status Verified Date:
2012-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this clinical research study is to develop observational clinical experience with the use of entecavir in participants who are either of BlackAfrican-American race or of Hispanic ethnicity
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None